SAIMA CHOHAN MD NPI 1073675526

NPI Details

Saima Chohan, MD is a rheumatology internal medicine in Phoenix, AZ with 28 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Saima Chohan, MD NPI is 1073675526. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE
Graduation Year:1998

The provider's business location address is:

4550 E BELL RD
SUITE 170
PHOENIX, AZ
ZIP 85032-306
Phone: (480) 443-8400
Fax: (480) 443-8697

The NPI 1073675526 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg (HCPCS:J7328)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, infliximab-abda, biosimilar, (renflexis), 10 mg (HCPCS:Q5104)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, rituximab-abbs, biosimilar, (truxima), 10 mg (HCPCS:Q5115)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Vitamin d-3 level (HCPCS:82306)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Analysis for antibody to coccidioides (bacteria) (HCPCS:86635)
• X-ray of hand, 2 views (HCPCS:73120)
• X-ray of foot, 2 views (HCPCS:73620)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Hepatitis c antibody measurement (HCPCS:86803)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
• Hepatitis b surface antibody measurement (HCPCS:86706)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Hepatitis b core antibody (igm) measurement (HCPCS:86705)
• Uric acid level, blood (HCPCS:84550)
• Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Tuberculosis test, gamma interferon (HCPCS:86480)
• Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment (HCPCS:77085)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Dxa bone density measurement of forearm, finger, hand, or foot (HCPCS:77081)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Complete ultrasound scan of joint (HCPCS:76881)
• Measurement of dna antibody, native or double stranded (HCPCS:86225)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Rheumatoid factor level (HCPCS:86431)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Urinalysis, manual test (HCPCS:81002)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• X-ray of knee, 3 views (HCPCS:73562)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Screening test for autoimmune disorder (HCPCS:86038)
• Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• X-ray of chest, 2 views (HCPCS:71046)

The enumeration date for this NPI number is 12/14/2006 and was last updated on 8/23/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.